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ABSTRACT
ALBERTI, M., C. GALVANI, M. EL GHOCH, C. CAPELLI, M. LANZA, S. CALUGI, and R. DALLE GRAVE. Assessment of
Physical Activity in Anorexia Nervosa and Treatment Outcome.Med. Sci. Sports Exerc., Vol. 45, No. 9, pp. 1643–1648, 2013. Purpose:
The aim of this study was to compare objective and subjective assessments of physical activity (PA) in patients with anorexia nervosa
and its effect on treatment outcome.Methods: Both Actiheart (AH) and International Physical Activity Questionnaire (IPAQ) were used
to assess PA in 52 female patients with anorexia nervosa during the first week of inpatient treatment. Results: No correspondence
between PA estimated by IPAQ, which had a tendency to underestimate PA, and that measured using AH emerged. However, a
significant association was found between the change in Eating Disorder Examination global score at the end of the treatment and light
PA measured by AH (beta = j0.12, t = j2.44, P = 0.019), but not that estimated by IPAQ. Conclusions: PA in patients with anorexia
nervosa is underestimated by subjective assessment when compared with objective measurement. Only time spent in light PA, assessed
objectively with AH, showed a negative association with improvement in eating disorder psychopathology. Key Words: EATING
DISORDERS, INPATIENT TREATMENT, PHYSICAL EXERCISE, ACCELEROMETER, OUTCOME
E
xcessive physical activity (PA) is a common behav-
ior observed among patients with anorexia nervosa
(11,37) and particularly in eating disorder inpatient
units, in which patients usually regain weight more rapidly
compared with outpatient settings (16). Excessive PA in
anorexia nervosa has been associated with an increased risk
of overuse injuries, bone fractures, and osteoporosis (26). It
tends to be seen in younger patients (37), in those with a
lower percentage of body fat (28) and body mass index
(BMI) (37), in those with greater severity of eating disorder
psychopathology (4,16,37,38) and general psychopathology
(4,38), and in those with specific personality features (e.g.,
perfectionism, high persistence, and low novelty seeking and
reward dependence) (16,37). It also seems to play an impor-
tant role in the development and maintenance of eating dis-
orders (19) and has been associated with longer inpatient
treatment (38), quicker relapse (39), and poor treatment
outcome (16).
Excessive PA may take different forms (25): it may be
incorporated into routine daily activities (e.g., walking most
of the hours in the day, standing rather than sitting while
studying, or watching television), structured sports activities
(e.g., training above and beyond a planned schedule or go-
ing to the gym several times a day), or abnormal exercising
(e.g., doing extreme numbers of push-ups or sit-ups at home
or in unusual places such as public rest rooms). This het-
erogeneity makes assessment of excessive PA a difficult
task. Many previous studies have relied on direct interview
or self-reported questionnaires to assess the role of excessive
PA in treatment outcome (10,16,39). However, as denial is a
common process in anorexia nervosa (41), it can be hy-
pothesized that some patients underestimate the amount of
their PA in such subjective methods, leading to significant
bias and therefore inaccuracy of data regarding both its ex-
tent and its role in treatment outcome. Indeed, the only two
studies to date comparing objective and subjective methods
of quantifying PA confirmed that patients with anorexia
nervosa underestimate the amount they do (8,40), whereas
females from the general population tend to overreport the
amount of PA measured by objective assessment (36). The
unreliability of patient reporting has led some authors to
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recommend the adoption of objective means of assessing PA
in anorexia nervosa, such as multiaxial waterproof activity
monitors (21).
To provide a clearer picture, the purposes of this study
were to compare such objective and subjective assessments
of PA in a large group of anorexia nervosa patients and to
explore any correlations with treatment outcome, something
that no study has yet undertaken.
METHODS
Participants
The sample consisted of 52 female patients consecutively
admitted to the eating disorder inpatient unit of Villa Garda
Hospital (Northern Italy) between January 2010 and April
2012. Patients were eligible to participate in the present
study if they met the following criteria: (a) age, 13–65 yr;
(b) BMI G 17.5 kgImj2; (c) diagnosis of anorexia nervosa
as determined by the Eating Disorder Examination interview
(24,32); and (d) failure of less intensive outpatient treatment
or an eating disorder of clinical severity not manageable in
an outpatient setting. Patients who were in an acute psychotic
state (N = 1) or had significant substance abuse problems
(N = 1) were excluded. Inclusion and exclusion criteria were
evaluated during an eligibility interview conducted by a spe-
cialist in the field (RDG).
The research was scrutinized and approved by the insti-
tutional review board of Villa Garda Hospital, Verona, and
all participants (or their legal guardians for patients younger
than 18 yr) gave informed written consent for the anony-
mous use of their personal data.
Treatment
The cognitive behavioral treatment that the patients un-
dertook has been described elsewhere (15,18). The treatment
is manual based, lasts 20 wk, and comprises 13 wk of in-
patient therapy followed by 7 wk of day-hospital. The treat-
ment included specific procedures and strategies to address
excessive PA (from light to vigorous) because its persis-
tence maintains the eating disorder psychopathology, ob-
structs weight restoration, and increases the risk of medical
complications (17). The main procedures and strategies
adopted were the following (17): (i) helping patients to de-
cide to address excessive PA using motivational enhance-
ment and educating them about the potential negative effects
of this form of PA; (ii) suggesting patients keep a real-time
monitoring record of the frequency, duration, and type of
PA they are engaged in; (iii) encouraging patients to sub-
stitute excessive PA with healthy and social exercising prac-
ticed, in the absence of medical contraindications, in twice
weekly sessions conducted by a physiotherapist; these ses-
sions include calisthenic exercises to improve the restoration
of muscular strength, flexibility, posture, and some aerobic
exercises to improve cardiovascular fitness; and (iv) helping
patients to adopt some functional mood modulatory behaviors
(e.g., listening music, taking a bath, and communicating with
others) and to use exercise as a means of modulating mood.
Assessment
Body weight and body mass index. Body weight and
height were measured, respectively, using medical weighing
scales and a stadiometer by a medical doctor involved in the
study. Participants were weighed before breakfast wearing
only underwear and no shoes. Their BMI was determined
according to the standard formula of body weight measured
in kilograms divided by height in meters squared.
PA assessment. All patients were subjected to both
objective and subjective assessment of their PA. Objective
PA assessment was carried out using Actiheart (AH), which
has been validated under different conditions (3,7,14) and
combines an HR monitor with a piezoelectric accelerometer
(frequency range of 1–7 Hz (3 dB)). AH is also able to as-
sess activity energy expenditure (AEE) and duration and
intensity of PA. An AH was placed on the left side of each
patient’s chest, attached to the skin by two standard ECG
electrodes, on the second day of hospitalization and was
kept in place for three consecutive days (72 h). To increase
the precision of the estimate of PA level using the PA
monitor, AH was individually calibrated as proposed by
Rennie et al. (35). For this purpose, we measured the resting
energy expenditure (REE) and the sleeping HR of our sub-
jects (two non–exercise-based individual calibrations). REE
was assessed using indirect calorimetry (Fitmate; Cosmed,
Rome, Italy) already validated in anorexia nervosa (23),
during a test lasting 15 min; the average of the values col-
lected between the 5th and the 10th minute was used to
calculate REE. This test was performed in the early morning,
while the subjects were lying quietly on a bed. Sleeping
HR was derived as the average of the highest values of the
30 lowest minute-by-minute HR readings during the 72-h
period (33).
The short, 7-d, self-administered format of the Interna-
tional Physical Activity Questionnaire (IPAQ) was used for
subjective PA assessment (13). IPAQ is an instrument de-
signed primarily for population surveillance of PA (13). It
covers three domains of PA: walking, moderate-intensity
activities, and vigorous-intensity activities. The questionnaire
also includes questions about time spent sitting as an indicator
of sedentary behavior. In each of the four domains, the number
of days per week and the time spent per day in both moderate
and vigorous activity or sedentary behavior during the last 7 d
are recorded. The IPAQ was administered to all patients on
the eighth day of hospitalization. IPAQ is considered to have
reasonable measurement properties for monitoring population
levels of PA in diverse settings.
The AH data collected were compared with the self-reported
PA estimates determined by IPAQ. The outcome measures
compared, expressed as mean daily values, were as follows:
AEE, minutes of moderate PA (MPA), minutes of vigorous PA
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(VPA), and sum of the minutes spent in moderate and vigorous
PA (MVPA). For both assessment tools, MPA was defined as
3–6 METs, and VPA was defined as 96 METs (34).
AEE and PA intensity readings from the AH were automat-
ically calculated according to the Branched model (Actiheart
Software, version 4.0; CamNtech, Inc., Cambridge, UK) [6])
and expressed in kilocalories per day and in METs, respec-
tively. To convert the results obtained from IPAQ to daily
AEE, we applied the following procedure. First, the selected
MET values were derived from data from the IPAQ reli-
ability study (13) and the compendium of Ainsworth et al.
(1). On the basis of these values, an average MET score was
assigned to each type of activity recorded with IPAQ.Walking
(all types of walking were included), moderate-intensity ac-
tivity, and vigorous-intensity activity were assigned average
values of 3.3, 4.0, and 8.0 METs, respectively. We then cal-
culated the total number of hours spent doing each of the three
activities during the 7-d period. Assuming that 1MET equaled
1 kcalIkgj1Ihj1 for all patients, the energy expenditure for
each type of activity for 7 d was calculated. The sum of these
daily expenditures yielded the total amount of energy spent
by a given subject for 1 wk, which, once divided by 7,
yielded the mean daily AEE in kilocalories per day (27,31).
Finally, the net AEE in kilocalories, that is, the activity above
the resting metabolic rate (i.e., the total AEE minus the REE),
was also calculated.
Eating disorder features. These were assessed using
the validated Italian version of the 12th edition of the Eating
Disorder Examination (EDE) interview (24,32). The EDE
was administered by assessors who were trained and super-
vised by RDG, an expert in the use of the tool. The assessors
had no involvement with the treatment itself. The main
outcome variable measured was the change in the severity of
eating disorder features, as measured by global EDE scores.
General psychiatric features. These were measured
using the validated Italian version of the Brief Symptom
Inventory from which a Global Severity Index was calcu-
lated (20,22).
Statistical Analysis
Statistical analysis was carried out by using StatView
version 5.0 and SPSS version 20.0 (SPSS Inc., Chicago, IL).
Continuous variables were categorized as mean T SD or
median (interquartile range), and categorical variables were
presented as frequency and percentage. Results were con-
sidered significant when P G 0.05.
A paired t-test was used to determine any differences be-
tween objective and subjective PA. A one-way ANOVA was
used to evaluate disparities between time spent in different
intensity thresholds with the Scheffe´ post hoc test. The sig-
nificance of any changes in clinical variables from baseline to
end-of-therapy scores was also determined in completers
using the t-test for paired data, or the McNemar test as ap-
propriate. Cohen’s d effect size was also determined.
Univariate regression analyses were performed to evalu-
ate the significance of associations between the PA mea-
sured objectively and estimated subjectively and the change
in EDE global score from baseline to the end of treatment.
Limits of correspondence were calculated as mean of the
difference j 2 SD and mean of the difference + 2 SD.
RESULTS
Clinical characteristics of participants. The char-
acteristics and clinical features of the sample are shown in
Table 1. The participants were all female, and 12 (23.1%)
were younger than 18 yr. All patients were extremely un-
derweight: 67.3% (35/52) had a BMI lower than 15.0 kgImj2,
and 86.5% (45/52) had received prior treatment for the illness.
TABLE 1. Clinical characteristics of the sample at baseline.
Age, mean (yr) 24.4 T 8.4
Marital status, n (%)
Single, never married 46 (88.5)
Married or living as such 6 (11.5)
Separated or divorced 0
Duration of eating disorder, median [IQR] (yr) 5 [9]
Lowest body mass index (kgImj2) 13.9 T 2.8
Highest body mass index (kgImj2) 21.2 T 2.9
Body weight (kg) 37.1 T 5.4
Body mass index (kgImj2) 14.3 T 1.7
Eating disorder psychopathology
Overall severity (global EDE) 3.8 T 1.3
Dietary restraint (EDE subscale) 4.2 T 1.5
Eating concern (EDE subscale) 3.5 T 1.5
Shape concern (EDE subscale) 4.0 T 1.5
Weight concern (EDE subscale) 3.6 T 1.8
Eating disorder behavior (EDE)
Objective bulimic episodes, n (%) present 15 (28.8)
If present, episodes/28 d, median [IQR] 10 [27]
Subjective bulimic episodes, n (%) present 27 (51.9)
If present, episodes/28 d, median [IQR] 12 [16]
Self-induced vomiting, n (%) present 16 (30.8)
If present, episodes/28 d, median [IQR] 21.5 [66]
Laxative misuse, n (%) present 6 (11.5)
If present, episodes/28 d, median [IQR] 11.5 [23]
Diuretic misuse, n (%) present 1 T 1.9
If present, episodes/28 d, median [IQR] —
General psychiatric features, GSI 87.7 T 19.2
Data are shown as mean T SD unless otherwise indicated.
IQR, interquartile range; EDE, Eating Disorder Examination (version 12.0D); GSI, Global
severity index.
TABLE 2. Comparison of AH and IPAQ measurement of PA in 52 patients with anorexia nervosa.
AH IPAQ Paired t-test P Effect Sizea
AEE (kcalIdj1) 471.0 T 240.5 89.5 T 156.6 11.41 G0.001 1.58
MPA (minIdj1) 93.5 T 111.9 50.9 T 84.9 2.41 0.020 0.33
VPA (minIdj1) 6.0 T 12.0 3.8 T 17.6 1.20 0.237 0.17
MVPA (minIdj1) 99.5 T 120.1 54.7 T 89.1 2.43 0.019 0.34
Data are presented as mean T SD.
aClassification of effect size: small, 90.20; moderate, 90.50; large, 90.80 (12,29).
AH, Actiheart; IPAQ, International Physical Activity Questionnaire; AEE, activity energy expenditure; MPA, minutes of moderate PA; VPA, minutes of vigorous PA; MVPA, sum of the
minutes spent in moderate and vigorous PA.
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PA assessment and characteristics. IPAQ assess-
ment was found to significantly underestimate PA in com-
parison with AH. In particular, AEE, MPA, and MVPA were
significantly lower when measured using IPAQ with respect
to AH. Only VPA showed no significant differences between
objective and subjective assessment (Table 2).
Data yielded by AH showed that our anorexia nervosa
patients spent significantly longer periods in activity classi-
fied as sedentary (SED) and light than performing activ-
ities classified as moderate or vigorous: SED, 495.0 T
189.1 minIdj1; light PA (LPA), 343.4 T 151.9 minIdj1;
MPA, 93.5 T 111.9 minIdj1; VPA, 6.0 T 12.0 minIdj1; and
MVPA, 99.5 T 120.1 minIdj1. Statistical analysis showed
that time spent in SED was significantly larger than that
spent in LPA, MPA, VPA, and MVPA (all P G 0.001); time
in LPA was significantly larger than that in MPA, VPA, and
MVPA (all P G 0.001); and finally, time spent in MPA was
significantly larger than that in VPA (P G 0.001). If the mi-
nutes spent in PA are analyzed on a patient-by-patient basis, a
great intrasubject variability is evident, with MPA ranging
from 499 to 0 minIdj1, VPA ranging from 65 to 0 minIdj1,
and MVPA ranging from 546 to 0 minIdj1. Indeed, the ac-
tivity pattern measured with AH was characterized by sev-
eral peaks throughout the day: one in the morning, one in
the late afternoon, and one after the evening meal (Fig. 1).
PA and treatment outcome. Forty-three patients
(82.7%) completed treatment, whereas nine patients (17.3%)
were classified as dropouts after a voluntary treatment dis-
continuation before the planned 20 wk had elapsed. The
mean T SD BMI of completers increased from 14.5 T
1.5 kgImj2 on admission to 19.0 T 1.0 kgImj2 at discharge
(t40 = j21.77, P G 0.001). Twenty-nine patients (70.7%)
reached a BMI Q 18.5.
Across the patient spectrum, the four EDE subscales, the
EDE global score, and the Brief Symptom Inventory were
significantly improved at the end of treatment. No significant
FIGURE 1—AN patient’s PA patterns depicted as mean T SD.
TABLE 3. Clinical state of the sample before and after treatment among those patients who completed treatment (N = 43).
Before Treatment After Treatment Effect Sizea
Body weight (kg) 37.5 T 5.3 49.4 T 4.6* 3.2
Body mass index (kgImj2) 14.5 T 1.5 19.0 T 1.0* 3.3
Eating disorder psychopathology
Overall severity (global EDE) 3.9 T 1.3 2.0 T 1.1* 1.7
Dietary restraint (EDE subscale) 4.2 T 1.6 1.5 T 1.1* 1.7
Eating concern (EDE subscale) 3.6 T 1.3 1.3 T 1.1* 1.8
Weight concern (EDE subscale) 3.8 T 1.7 2.3 T 1.4* 1.0
Shape concern (EDE subscale) 4.1 T 1.6 2.9 T 1.5* 0.8
Eating disorder behaviors (EDE)
Objective bulimic episodes, n (%) present 12 (27.9) 7 (16.3)
If present, episodes/28 d, median [IQR] 19 [69] 4 [3]
Objective bulimic episodes, n (%) present 25 (58.1) 18 (41.9)
If present, episodes/28 d, median [IQR] 12 [16] 3 [8]
Self-induced vomiting, n (%) present 13 (30.2) 9 (20.9)
If present, episodes/28 d, median [IQR] 28 [92] 4 [5]
Laxative misuse, n (%) present 6 (14.0) 1 (2.3)
If present, episodes/28 d, median [IQR] 11.5 [23] —
Diuretic misuse, n (%) present 1 (2.3) —
If present, episodes/28 d, median [IQR] —
General psychiatric features, GSI 87.5 T 18.9 63.3 T 14.7* 1.4
Data are shown as mean T SD unless otherwise stated.
*P G 0.05.
aClassification of effect size: small, 90.20; moderate, 90.50; large, 90.80 (12,29).
IQR, interquartile range; EDE, Eating Disorder Examination (version 12.0D); GSI, Global severity index.
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differences were found in the number of objective and sub-
jective bulimic episodes, episodes of self-induced vomiting,
or laxative misuse (Table 3).
Linear regression analyses showed that only LPA mea-
sured by AH was significantly and negatively related with
the change in global EDE score from admission to discharge
(beta = j0.12, t = j2.44, P = 0.019).
DISCUSSION
The main findings of the present study were as follows: (i)
the levels of PA assessed using subjective IPAQ were sig-
nificantly below those objectively measured using AH; (ii)
patients with anorexia nervosa spend significantly longer
periods in activity classified as sedentary and light, as com-
pared with activities classified as moderate or vigorous; and
(iii) higher LPA in the first days of inpatient treatment seems
to be associated with less improvement in eating disorder
psychopathology at the end of the program.
The study has two main strengths. First, the assessment
of PA was performed using AH, a multisensor instrument
that provides better accuracy than single sensor systems
(2). The AH also has other advantages: it is waterproof and
does not interfere with the performance of daily activities,
and it allows nonwearing times to be easily identified, as its
displacement causes a detectable loss of HR signal (42).
Second, this is one of very few studies that have attempted
a longitudinal assessment of the influence of objectively
measured PA levels on treatment outcome using the EDE, a
gold-standard instrument for assessing eating disorder psy-
chopathology. Limitations of the study include the absence
of a control group, the absence of longitudinal assessment of
PA, and the evaluation of a single inpatient unit. Confir-
mation of our results using other inpatient and outpatient
samples is therefore required. Finally, the IPAQ, a question-
naire developed to measure health-related PA in populations,
might not be the most reliable tool to assess self-reported PA
in patients with anorexia nervosa, who exercise mainly to
control their shape and body weight in an inappropriate way.
New investigations may be needed to evaluate the results
obtained in this specific population using alternative PA es-
timation questionnaires.
Indeed, our data are difficult to compare with existing find-
ings because different methods of PA assessments, sample
sizes (from 6 to 36 subjects), lengths of PA monitoring pe-
riod (from 2 to 7 d), and settings (inpatient, outpatient, and
free living) have been used. Nevertheless, our data do confirm
the results of the two previous studies in that it was observed
that patients with anorexia nervosa tend to underreport the
amount of daily PA they perform (8,40). In addition, the
minutes per day of MVPA assessed by AH in our study are
close to those measured by Bratland-Sanda et al. (9) in a
population of seven inpatients with anorexia nervosa using
an accelerometer (MVPA, 100 vs 93 minIdj1). Conversely,
Hechler et al. (28) found far higher objective PA levels in
outpatients with anorexia nervosa (232 minIdj1 from low to
very high PA) than those measured in our sample. Time
spent in sedentary activities in our sample is consistent with
the data of Bouten et al. (5) when expressed as a percentage
of monitoring time (53% vs 60%), but higher than the per-
centage of time spent in LPA, MPA, or VPA.
As previously observed (30), our data indicate that some
patients with anorexia nervosa are consistently more active
than others, in particular those with shorter duration of the
disorder, with MVPA showing an interperson variation by
up to 500 minIdj1. Despite the great range in MVPA across
individuals, our data show a PA pattern common to in-
patients with anorexia nervosa, featuring three distinct peaks
during the day (in the midmorning, late afternoon, and after
dinner).
Finally, the negative relation between change in global
EDE score and baseline levels of LPA indicates that patients
with a higher LPA in the first days of inpatient treatment
show less improvement in their eating disorder psychopa-
thology. The design of our study does not enable light to be
shed on the reasons for this association, although we can
speculate that excessive LPA, unlike MPA and VPA, is a
behavior that is difficult to detect and may not have been
adequately addressed by the treatment. As a consequence,
the possible maintenance of high levels of LPA may have
hindered improvement in the eating disorder psychopathol-
ogy. Future studies, with a larger sample size, designed to
assess LPA levels during the course or at the end of treat-
ment, are needed to test this hypothesis.
Although methodological limitations preclude any firm
conclusions, our data do have some clinical implications.
First, the self-reported assessment of PA of patients with
anorexia nervosa seems to be of scarce clinical utility, pri-
marily because it provides greatly underestimated figures
when compared with objective measurement and because it
exhibits no association with treatment outcome. Our second
interesting finding was that higher levels of LPA, assessed
using AH, in the first days of inpatient treatment, are asso-
ciated with poorer improvement of eating disorder psycho-
pathology. This indicates the utility of including objective
measurement of PA in the assessment of patients with an-
orexia nervosa. Third, our data suggest the need to devise
additional strategies for the first week of inpatient cognitive
behavioral treatment for patients with high levels of LPA, in
particular to help them cope with the urge to exercise, which
seems likely to strike in the midmorning, late afternoon, and
after their evening meal.
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